GlaxoSmithKline is a large British pharmaceutical company headquartered in London. Some key facts: - Formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. - Had revenue of £28.39 billion and net income of £1.85 billion in 2010. - Employs over 96,500 people worldwide and operates in pharmaceuticals, vaccines, consumer healthcare and nutritional products. - Between 2007-2010 its compound annual growth rate for sales was lower than the overall pharmaceutical industry average, indicating slower growth compared to its peers.

1. GlaxoSmithKline
Pharmaceutical
Submitted To,
Prof. Ramesh .S

2. Type Public limited company
LSE:
Traded as
NYSE:
Industry Pharmaceutical, biotechnology
Glaxo Wellcome
Predecessor(s)
SmithKline Beecham
Founded 2000 (London)
Headquarters London, United Kingdom
Chris Gent (Chairman)
Key people
Andrew Witty (Chief Executive)
Pharmaceuticals, vaccines, oral healthcare
Products products, nutritional products, over-the-counter
medicines
Revenue £28.392 billion (2010)[1]
Net income £1.853 billion (2010)[1]
Total equity £9.745 billion (2010)[2]
Employees 96,500 (2010

3. Compound Annual Growth
Rate - CAGR
 The year-over-year growth rate of an
investment over a specified period of
time.
 Formula for CAGR
[{Current value of sales/value of sales
from base year]1/n -1}* 100]

4. GLAXOSMITHKLINE
PHARMACEUTICALS (CAGR)
Year 2010 2009 2008 2007 2006
Net Sales 2,125.20 1,884.14 1,676.36 1,578.58 1,541.93
PAT 563.69 512.29 576.57 537.66 545.51
CAGR 8.35% 5.14% 2.11% 0.59%
(Sales)
CAGR 0.82% -1.56% 1.39% -0.36%
(PAT)

5. 10.00%
8.00%
6.00%
4.00%
CAGR (Sales)
CAGR (PAT)
2.00%
0.00%
2010 2009 2008 2007
-2.00%
-4.00%

6. CAGR of Industry (Sales)
Year 2010 2009 2008 2007 2006
RANBAXY 5,646.37 4,781.59 4,652.04 4,293.02 4,165.12
LUPIN LTD 3,690.09 2,954.70 2,575.39 1,985.79 1,652.93
DR.REDDY'S
4,395.60 3,999.50 3,343.89 3,783.26 2,003.26
LAB
Glaxos
2,125.20 1,884.14 1,676.36 1,578.58 1,541.93
mith
Total 15857.26 13619.93 12247.66 11640.65 9363.24
CAGR 14.08% 9.82% 6.94% 5.59%

7. CAGR of Industry (PAT)
Year 2010 2009 2008 2007 2006
RANBAXY 1,148.73 571.98 -1,044.80 617.72 380.54
LUPIN LTD 648.93 416.97 443.38 302.06 182.72
DR.REDD
846.10 560.90 475.22 1,176.86
Y'S LAB 211.12
Glaxos
563.69 512.29 576.57 537.66 545.51
mith
TOTAL 3207.45 2062.14 450.37 2634.3 1319.89
CAGR 24.85% 11.80% -23.57% 18.86%

8. Industry Vs. Glaxosmith
YEAR 2010 2009 2008 2007
Glaxosmith 8.35% 5.14% 2.11% 0.59%
Industry
14.08% 9.82% 6.94% 5.59%
16.00%
14.00%
12.00%
10.00%
8.00% Glaxosmith
6.00% Industry
4.00%
2.00%
0.00%
2010 2009 2008 2007

9. Thank You